Emerging Markets Earnings Roundup: Amgen, Bristol Myers Squibb (Part 1)
This article was originally published in PharmAsia News
Executive Summary
After tackling Brazil and Turkey, Amgen looks to ramp up in Japan and China, while BMS talks up its first-to-market opportunity for an all-oral hepatitis C regimen in Japan.